Prescription ADHD could be as bad as the opioid crisis, the Drug Enforcement Administration warns in a scathing letter to pharma
The Drug Enforcement Administration (DEA) has expressed concern that “aggressive marketing practices” by telehealth companies may contribute to overprescribing of medications used to treat attention deficit hyperactivity disorder (ADHD), according to a letter from the agency. Although the letter does not refer to specific companies, it is believed to refer to telehealth companies such as …